Ayer Capital Management

Ayer Capital Management as of March 31, 2012

Portfolio Holdings for Ayer Capital Management

Ayer Capital Management holds 34 positions in its portfolio as reported in the March 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Teva Pharmaceutical Industries (TEVA) 9.4 $19M 414k 45.06
McKesson Corporation (MCK) 9.1 $18M 204k 87.77
Grifols S A 6.5 $13M 1.7M 7.71
Intermune cv 5.0% 6.0 $12M 11M 1.12
CIGNA Corporation 5.6 $11M 225k 49.25
Dynavax Technologies Corporation 5.4 $11M 2.1M 5.06
Cardinal Health (CAH) 5.1 $10M 235k 43.11
Oncothyreon 5.0 $9.9M 2.3M 4.36
Halozyme Therapeutics (HALO) 5.0 $9.8M 771k 12.76
Ariad Pharmaceuticals 4.9 $9.7M 609k 15.95
Novartis (NVS) 4.4 $8.7M 156k 55.41
Dendreon Corp cnv 4.3 $8.5M 6.2M 1.37
Sanofi-Aventis SA (SNY) 2.9 $5.7M 148k 38.75
NPS Pharmaceuticals 2.7 $5.3M 778k 6.84
D Horizon Pharma 2.6 $5.1M 1.4M 3.73
Chemocentryx 1.9 $3.8M 355k 10.66
Synta Pharmaceuticals 1.9 $3.7M 852k 4.35
Celldex Therapeutics 1.6 $3.1M 614k 5.09
Biolinerx Ltd-spons 1.5 $3.0M 1.1M 2.86
Array BioPharma 1.5 $2.9M 865k 3.40
BioSpecifics Technologies 1.4 $2.8M 175k 15.82
Threshold Pharmaceuticals 1.4 $2.7M 312k 8.80
Trius Therapeutics 1.4 $2.7M 509k 5.35
SciClone Pharmaceuticals 1.1 $2.1M 338k 6.31
Biomira Inc Cmn Stock cmn 1.1 $2.1M 489k 4.36
Uroplasty 1.1 $2.1M 688k 3.01
GTx 1.0 $1.9M 500k 3.85
Cyclacel Pharmaceuticals 0.9 $1.8M 2.6M 0.70
Sucampo Pharmaceuticals 0.8 $1.5M 204k 7.45
Verastem 0.7 $1.4M 128k 10.93
Alexza Pharmaceuticals 0.6 $1.2M 2.0M 0.62
Celgene Corporation 0.6 $1.2M 602k 1.95
UnitedHealth (UNH) 0.5 $1.1M 18k 58.93
Inovio Pharmaceuticals 0.4 $788k 1.2M 0.66